The National Annual Agreement Review meeting planned for tomorrow has been postponed until 24 June because Health New Zealand Te Whatu Ora does not yet know how much money it will allocate to pharmacy funding
The lack of additional investment in New Zealand’s medicines budget, especially the failure to announce the funding of 13 cancer-drug treatments promised before the election is extremely disappointing
Budget 2024: Aside from a glaring hole where new funding for Pacific providers should be, there are no surprises in the Vote Health section of the 2024 Budget, says public health academic Sir Collin Tukuitonga
Budget 2024: Health economist Paula Lorgelly says many Kiwis who were expecting more funding for new cancer drugs and for Pharmac will be sadly disappointed by Budget 2024, which she sees as underwhelming.
Former deputy prime minister Paula Bennett has been appointed Pharmac’s new board chair, as the Government pledged to boost the agency’s funding by around $400 million a year over the next four years
A long-serving health official says the increase in bureaucracy at Te Whatu Ora is “out of control”, despite the rest of the public service facing drastic cutbacks
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes